Clinical Trial Update: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise [Phase 3]

View source ↗

Summary

A Phase III trial update on the efficacy and safety of GZR18 Injection in adults with Type 2 Diabetes Mellitus and poor glycemic control, currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: ACTIVE_NOT_RECRUITING